ArticleNature communications2025
A Pseudomonas aeruginosa quorum-sensing inducer controls lung permeability in establishing chronic infection via EGFR.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pseudomonas aeruginosa is an opportunistic pathogen that can cause severe infections in immunocompromised patients. N-(3-oxo-dodecanoyl) homoserine lactone (3oc12) is a small quorum molecule that is used to communicate between bacterial cells and between bacteria and the host. However, the exact molecular mechanisms of this exchange is not yet fully understood. Here, we present a modality that P. aeruginosa uses to finetune the severity of lung infection, where 3oc12 is incorporated into the host cell membrane, causing a marked increase in epidermal growth factor receptor (EGFR) ligand-independent self-dimerization. This ligand-free self-activation leads to epidermal growth factor receptor-signal transducer activator of transcription-3 (EGFR-STAT3) signaling, resulting in higher expression of tight junction proteins. This effect reduces the permeability of lung epithelial barrier, which in turn inhibits the release of P. aeruginosa from alveoli into the systemic circulation, and is essential to the establishment of long-term infection. This finding suggests a new, pathogen-autonomous mechanism to describe a tendency of P. aeruginosa of maintaining persistent chronic infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.